Answers are grounded in this paper and cite their sources.
A unanimous vote last week by advisers to the U.S. Food and Drug Administration is likely to sharply curtail access in America to the breast cancer drug Avastin.
No takes yet. Share an insight, caveat, or question.
Couzin-Frankel et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: